언어 선택

HLA-A*0201 & B2M & KRASG12D (KLVVVGADGV)

HLA-A*0201 & B2M & KRASG12D (KLVVVGADGV) 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
His Tag & Avi Tag (1)
마커
Biotin-labeled (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
HLD-H82E4	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&KRASG12D (KLVVVGADGV) Complex Protein (Monomer, MALS verified)

총 수량1

HLA-A*0201 & B2M & KRASG12D (KLVVVGADGV)분자 배경

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Human HLA-A*0201 KRAS (KLVVVGAGGV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and KLVVVGAGGV peptide of the KRAS.

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
IBC-0966	IBC-0966	Phase 2 Clinical	SunHo (China) BioPharmaceutical Co Ltd	Neoplasms	상세
BI-765063	OSE-172; BI-765063	Phase 1 Clinical	Ose Immunotherapeutics	Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung	상세
Anzurstobart	BMS-986351; CC-95251	Phase 1 Clinical	Celgene Corp	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
ADU-1805	ADU-1805	Phase 1 Clinical	Aduro Biotech Inc	Solid tumours; Neoplasms; Neoplasm Metastasis	상세
LM-101	LM-101	Phase 1 Clinical	LaNova Medicines Ltd	Leukemia; Solid tumours; Hematologic Neoplasms; Neoplasms	상세
Q-1801	Q-1801; Q 1801	Phase 1 Clinical	Qiyu Biotechnology (Shanghai) Co Ltd	Solid tumours	상세
Recombinant humanized IgG4 anti-SIRPα antibody（Daiichi Sankyo）	DS-1103a	Phase 1 Clinical	Daiichi Sankyo Co Ltd	Solid tumours; Breast Neoplasms	상세
ELA-026	ELA-026	Phase 1 Clinical	Electra Therapeutics Inc	Lymphohistiocytosis, Hemophagocytic	상세
BYON-4228	BYON-4228	Phase 1 Clinical	Byondis Bv	Solid tumours; Lymphoma	상세
BSI-082	BSI-082	Phase 1 Clinical	Boaoxin Biotechnology(Nanjing) Co Ltd	Hematologic Neoplasms; Solid tumours	상세
BR-105	BR-105; BR105	Phase 1 Clinical	BioRay Pharmaceutical Co Ltd	Neoplasms; Lymphoma, Large B-Cell, Diffuse	상세
[89Zr]Zr- BI-765063(Boehringer Ingelheim)		Phase 1 Clinical	Boehringer Ingelheim Corp	Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma	상세
TQB-2928	TQB-2928	Phase 1 Clinical		Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute	상세
BI-765080		Phase 1 Clinical	C.H. Boehringer Sohn Ag & Co. Kg		상세
ES-004	ES-004; ES 004-N4; ES 004-B4	Phase 1 Clinical		Solid tumours; Neoplasms	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Relugolix/Estradiol/Norethindrone Acetate	E2/NETA	Approved	Myovant Sciences	MYFEMBREE, RYEQO	United States	Menorrhagia; Leiomyoma	Myovant Sciences	2021-05-26	Pain; Endometriosis; Leiomyoma; Menorrhagia; Uterine Neoplasms	상세
Elagolix/estradiol/norethindrone acetate		Approved	Abbvie Inc	Oriahnn	United States	Menorrhagia	Abbvie Inc	2020-05-29	Menorrhagia	상세